Endocyte

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Endocyte ( ECYT) is a biopharmaceutical company. Endocyte is engaged in developing therapies for the treatment of cancer and inflammatory diseases. This stock is trading up 12.2% at $5.50 in recent trading.

Today's Range: $4.93-$5.78

52-Week Range: $3.02-$14.80

Volume: 2.2 million

Three-Month Average Volume: 867,048

>>7 Cancer Drug Stocks to Know Right Now

From a technical perspective, ECYT is ripping higher today off some near-term previous support at $4.83 with monster volume. This move is quickly pushing ECYT within range of triggering a big breakout. That breakout will trigger once ECYT takes out some near-term overhead resistance at $6.48 with volume.

Traders should now look for long-biased trades if EYCT can sustain a high-volume move and close over $6.48. Look for volume on that move that's near or well above 867,048 shares. If we get that action soon, then look for ECYT to make a run at its 200-day moving average of $8.68 in the near future.

If you liked this article you might like

Biotech M&A: Who's Next After Gilead-Kite?

'Longing' for Acadia Pharmaceuticals? Here's How to Play It

3 Housing Plays With Solid Earnings

7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods

Jana Partners Liquidates Whole Foods Stake After Engineering Industry-Transforming Sale To Amazon